Imaging features of triple-negative breast cancers according to androgen receptor status.

•TNBC is a heterogeneous collection of breast cancers that is defined by the lack of ER, PR and HER-2 expression.•The luminal androgen receptor (LAR) subtype of TNBC is associated with lower rates of pathologic complete response.•Androgen receptor (AR) status is a surrogate immunohistochemical marker for the LAR subtype of TNBC.•Imaging surrogates of the chemoresistant LAR subtype could also be potentially identified.•AR+ TNBC significantly associates with masses with high density, calcifications, and irregular shape.